Browsing: Wellness Tips

One of my favorite movies of all time is Annie Hall, starring the late, great Diane Keaton. However, the original name of Woody Allen’s classic was “Anhedonia.” The studios didn’t think that title was marketable because it means the inability to feel pleasure. Probably not the best choice for a rom-com

Over the past five years, medications called GLP-1s have revolutionized the treatment of metabolic disorders like obesity, diabetes and fatty liver diseases. Sold under the brand names Ozempic, Wegovy, Mounjaro and Zepbound, these drugs are highly effective at helping people lose weight and manage their blood sugar levels

GLP-1 receptor agonist drugs have long been used to treat diabetes and, more recently, obesity. Now, researchers are studying whether the medications could also help prevent opioid addiction relapse

Assam is currently grappling with a concerning surge in obesity among its younger population, a trend largely attributed to profound changes in modern lifestyles. Rapid modernization, technological advancements, and increasing urbanization have ushered in an era of comfort and convenience, inadvertently fostering habits detrimental to health

Just three minutes of sprinting may produce a molecular response that looks very different from what happens after 90 minutes of moderate exercise

Researchers at McMaster University have uncovered an unexpected role for a naturally occurring hormone already known for reducing appetite and supporting weight loss. The hormone appears to protect the liver from inflammation through a previously unknown signaling pathway, a finding that could point toward new approaches for treating advanced fatty liver disease

Men with heart disease are at a higher risk of developing and dying from cancer, new research suggests

Billy Gardell celebrated his 57th birthday on August 20 and the Mike & Molly actor has been thriving in this new era of his life

Millions of people in the U.S. are taking injectable GLP-1 drugs for weight loss, and now there is even a CMS subsidy for certain GLP-1 medications. But the drug hasn’t had much of an impact on senior living operations or residents thus far

Roche’s Genentech is pledging $750 million to double the size of its Oregon manufacturing site and create more jobs, a move designed to expand the company’s capacity to make injectable medicines and delivery devices